Format

Send to

Choose Destination
Curr Opin Pharmacol. 2008 Jun;8(3):255-60. doi: 10.1016/j.coph.2008.03.003. Epub 2008 May 28.

Vascular endothelial growth factor of the lung: friend or foe.

Author information

1
Program in Translational Lung Research, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Colorado Denver, School of Medicine, Denver, CO 80262, United States. Rubin.Tuder@uchsc.edu

Abstract

The discovery of vascular endothelial growth factor (VEGF) changed the field of angiogenesis. We have learned that VEGF has broader actions than merely a driver of tumor angiogenesis, particularly that VEGF controlled several fundamental functions and properties of endothelial cells and nonendothelial cells. The lung is one of the main organs where VEGF controls several crucial physiological functions. These actions rely on tightly regulated temporal and concentration gradients of VEGF and VEGF receptor expression in the lung. Excessive or diminished VEGF have been linked to abnormal lung phenotypes and, in humans, linked to several diseases. The beneficial and detrimental actions of VEGF underscore that therapeutic targeting of VEGF in disease has to carefully consider the lung biology of VEGF.

PMID:
18468486
PMCID:
PMC2622735
DOI:
10.1016/j.coph.2008.03.003
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center